PreNatal 19 Chewable Tablets

Nationwide Laboratories PreNatal 19 Chewable Tablets -

Product Type

Packaging Size

100.0 Tablet(s)

Serving Size

1.0 Tablet(s)

UPC

342937707103

Ingredients

Description

N Rx only A Presecription Prenatal Vitamin with other Vitamins and Minerals for Nutritional Supplementation PHARMACIST: Dispense in a tight, light?resistant container as defined in the USP/NF with child-resistant closure. HOW SUPPLIED: PreNatal 19 chewable tablets for oral administration are supplied as multi-color-speckled,round tablets debossed "C43", packaged in bottles of 100 tablets. DESCRIPTION: PreNatal 19 chewable tablets are round, debossed "C43". These tablets provide oil-soluble vitamins and minerals. Rev. 12/12

Formulation

INDICATIONS: PreNatal 19 chewable tablets are indicated for use in improving the nutritional status of women throughout pregnancy and in postnatal period for both lactating and non-lactating mothers. PreNatal 19 chewable tablets are also useful in improving the nutritional status of women prior to conception.

Precautions

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of the reach of children. In case of accidental overdose, call a doctor or poison control center immediately. CONTRAINDICATIONS: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients. WARNINGS: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. Call your doctor about side effects. You may report side effects to FDA at 1-800-FDA-1088. All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. This product may be administered only under a physician's supervision. PRECAUTIONS: Folic acid in doses above 0.1 mg daily may obscure pernicious anemia, in that hematological remission can occur while neurological manifestations remain progressive.

Related Products